INVZ vs. DNA

Last updated Apr 1, 2026

Compare and contrast key facts about Innoviz Technologies Ltd. (INVZ) and Ginkgo Bioworks Holdings, Inc. (DNA).

Performance

INVZ vs. DNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Innoviz Technologies Ltd. (INVZ) and Ginkgo Bioworks Holdings, Inc. (DNA). The values are adjusted to include any dividend payments, if applicable.

INVZ vs. DNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
INVZ Innoviz Technologies Ltd.	-25.86%	-49.22%	-33.60%	-35.62%	-38.01%	-31.53%
DNA Ginkgo Bioworks Holdings, Inc.	-26.23%	-15.38%	-85.47%	0.00%	-79.66%	-17.89%

Fundamentals

Market Cap INVZ : $133.10M DNA : $339.96M
EPS INVZ : -$0.33 DNA : -$5.65
PS Ratio INVZ : 2.35 DNA : 1.99
PB Ratio INVZ : 1.71 DNA : 0.67
Total Revenue (TTM) INVZ : $55.09M DNA : $170.16M
Gross Profit (TTM) INVZ : $12.91M DNA : $138.63M
EBITDA (TTM) INVZ : -$61.45M DNA : -$215.86M

Returns By Period

The year-to-date returns for both stocks are quite close, with INVZ having a -25.86% return and DNA slightly lower at -26.23%.

INVZ

• 1D: 7.20%
• 1M: -25.84%
• YTD: -25.86%
• 6M: -69.00%
• 1Y: -2.98%
• 3Y*: -43.46%
• 5Y*: —
• 10Y*: —

DNA

• 1D: 11.86%
• 1M: -9.19%
• YTD: -26.23%
• 6M: -57.96%
• 1Y: 7.54%
• 3Y*: -51.34%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

INVZ vs. DNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INVZ

INVZ Risk / Return Rank: 42
INVZ Sharpe Ratio Rank: 39
INVZ Sortino Ratio Rank: 48
INVZ Omega Ratio Rank: 44
INVZ Calmar Ratio Rank: 40
INVZ Martin Ratio Rank: 39

DNA

DNA Risk / Return Rank: 46
DNA Sharpe Ratio Rank: 45
DNA Sortino Ratio Rank: 53
DNA Omega Ratio Rank: 51
DNA Calmar Ratio Rank: 42
DNA Martin Ratio Rank: 42

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INVZ vs. DNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Innoviz Technologies Ltd. (INVZ) and Ginkgo Bioworks Holdings, Inc. (DNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	INVZ	DNA	Difference
Sharpe ratio Return per unit of total volatility	-0.03	0.08	-0.11
Sortino ratio Return per unit of downside risk	0.72	0.86	-0.14
Omega ratio Gain probability vs. loss probability	1.07	1.10	-0.03
Calmar ratio Return relative to maximum drawdown	-0.05	0.00	-0.06
Martin ratio Return relative to average drawdown	-0.11	0.01	-0.11
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

INVZ vs. DNA - Sharpe Ratio Comparison

The current INVZ Sharpe Ratio is -0.03, which is lower than the DNA Sharpe Ratio of 0.08. The chart below compares the historical Sharpe Ratios of INVZ and DNA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	INVZ	DNA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.03	0.08	-0.11
Sharpe Ratio (All Time) Calculated using the full available price history	-0.48	-0.59	+0.12

Correlation

The correlation between INVZ and DNA is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

INVZ vs. DNA - Dividend Comparison

Neither INVZ nor DNA has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

INVZ vs. DNA - Drawdown Comparison

The maximum INVZ drawdown since its inception was -96.06%, roughly equal to the maximum DNA drawdown of -99.10%. Use the drawdown chart below to compare losses from any high point for INVZ and DNA.

Drawdown Indicators

	INVZ	DNA	Difference
Max Drawdown Largest peak-to-trough decline	-96.06%	-99.10%	+3.04%
Max Drawdown (1Y) Largest decline over 1 year	-75.21%	-66.05%	-9.16%
Current Drawdown Current decline from peak	-94.88%	-98.97%	+4.09%
Average Drawdown Average peak-to-trough decline	-74.14%	-78.98%	+4.84%
Ulcer Index Depth and duration of drawdowns from previous peaks	36.92%	32.41%	+4.51%

Volatility

INVZ vs. DNA - Volatility Comparison

The current volatility for Innoviz Technologies Ltd. (INVZ) is 16.06%, while Ginkgo Bioworks Holdings, Inc. (DNA) has a volatility of 28.02%. This indicates that INVZ experiences smaller price fluctuations and is considered to be less risky than DNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	INVZ	DNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.06%	28.02%	-11.96%
Volatility (6M) Calculated over the trailing 6-month period	52.70%	73.00%	-20.30%
Volatility (1Y) Calculated over the trailing 1-year period	92.77%	100.38%	-7.61%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	88.95%	96.65%	-7.70%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	88.95%	96.65%	-7.70%

Financials